Harlan Laboratories Contract Research Services (CRS) is investing $4.5 million in its Itingen, Switzerland site. The investment will expand its range of testing and research services at the site and will include enhancements to the inhalation facility, upgrading the barrier protected area for chronic and subchronic studies and an entire floor dedicated to reproductive and rodent toxicology. The company will also build new lab areas for clinical diagnostics, biochemical analysis and fetal patholo...